Medicure (CVE:MPH) Share Price Crosses Below Two Hundred Day Moving Average of $1.23

Medicure Inc. (CVE:MPHGet Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$1.23 and traded as low as C$1.08. Medicure shares last traded at C$1.11, with a volume of 600 shares changing hands.

Medicure Stock Up 1.8 %

The company has a market cap of C$11.59 million, a price-to-earnings ratio of -12.33 and a beta of 1.01. The business’s 50 day simple moving average is C$1.06 and its 200-day simple moving average is C$1.23. The company has a debt-to-equity ratio of 2.73, a quick ratio of 1.29 and a current ratio of 1.92.

Medicure (CVE:MPHGet Free Report) last released its quarterly earnings results on Monday, April 8th. The company reported C($0.14) earnings per share for the quarter. The business had revenue of C$5.07 million for the quarter. Medicure had a negative net margin of 4.25% and a negative return on equity of 4.51%. Sell-side analysts expect that Medicure Inc. will post 0.0749258 earnings per share for the current year.

About Medicure

(Get Free Report)

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.

Featured Articles

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.